Hemostasis Today

March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Tareq Abadl: Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?
Mar 3, 2026, 15:34

Tareq Abadl: Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?

Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:

”Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?

When a CBC reports thrombocytopenia, the laboratory’s role doesn’t end with releasing a number.
That’s where the real investigation begins.

What Are Schistocytes?

Schistocytes are fragmented red blood cells seen on a peripheral blood smear.
They result from mechanical destruction of RBCs as they pass through vessels containing microthrombi or fibrin strands.

In simple terms:
They are evidence of red cell injury happening inside the bloodstream.

Why Should We Look for Them in Thrombocytopenia?

Because an increased schistocyte count (≥1%) may indicate a life-threatening condition known as: Microangiopathic Hemolytic Anemia (MAHA)

Major causes include:

  • Thrombotic Thrombocytopenic Purpura (TTP)
  • Hemolytic Uremic Syndrome (HUS)
  • Disseminated Intravascular Coagulation (DIC)

What Happens in These Conditions?

  • Mechanical destruction of RBCs
  • Rapid platelet consumption
  • Hemolytic anemia
  • Possible renal or neurological involvement

This is not just thrombocytopenia.
This is a hematologic emergency.

Key Laboratory Takeaway

  • In a patient with low platelets, detecting schistocytes on a peripheral smear is not a minor detail — it may be the first warning sign of a critical microangiopathic process.
  • Automated analyzers are powerful.
    But the manual blood smear still saves lives.

Tareq Abadl: Why Is Measuring Schistocytes Critical in a Thrombocytopenic Patient?

Find more posts featuring Tareq Abadl on Hemostasis Today.